Matinas BioPharma Hldgs Stock (AMEX:MTNB), Quotes and News Summary

Q: What sector and industry does Matinas BioPharma Hldgs (MTNB) operate in?

Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Matinas BioPharma Hldgs Stock (AMEX: MTNB) stock price, news, charts, stock research, profile.

Open	$0.192
Close	$0.190
Volume / Avg.	957.887K / 1.530M
Day Range	0.180 - 0.198
52 Wk Range	0.110 - 0.890
Market Cap	$47.655M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	38
Short Interest	1.34%
Days to Cover	1

Recent News

Why Is Fungal Infections-Focused Matinas BioPharma Stock Trading Higher On Friday?

Progress with Matinas BioPharma's MAT2203 for invasive fusarium infection. Clinical response achieved in patients resistant to other antifungals.

Vandana Singh

Why Reneo Pharmaceuticals Shares Are Trading Higher By Around 14%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

Shares of Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM) shares rose sharply during Wednesday’s session after Concentra sent an acquisition proposal to acquire 100% of equity of the company for $1.80 per share. Reneo Pharmaceuticals shares climbed 13.6% to $1.59 on Wednesday.

Avi Kapoor

Why Is Inflammatory Focused Matinas BioPharma Stock Trading Higher Today?

Wednesday, Matinas BioPharma Holdings Inc (NASDAQ: MTNB) announced results from a series of in vivo studies demonstrating successful oral delivery of two lipid nanocrystal (LNC)-formulated small single-strand oligonucleotides targeting inflammatory cytokines TNFα and IL-17

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Matinas Biopharma Holdings Inc

Sector

Health Care

Industry

Biotechnology

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identif...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Matinas BioPharma Hldgs (MTNB) stock?

You can purchase shares of Matinas BioPharma Hldgs (AMEX: MTNB) through any online brokerage.

View our list of the best stock brokerages.

Who are Matinas BioPharma Hldgs's (MTNB) competitors?

Other companies in Matinas BioPharma Hldgs’s space includes: Vaxxinity (NASDAQ:VAXX), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS) and Eagle Pharmaceuticals (NASDAQ:EGRX).

What is the target price for Matinas BioPharma Hldgs (MTNB) stock?

The latest price target for Matinas BioPharma Hldgs (AMEX: MTNB) was reported by BTIG on Wednesday, October 11, 2023. The analyst firm set a price target for 3.00 expecting MTNB to rise to within 12 months (a possible 1447.99% upside). 1 analyst firms have reported ratings in the last year.

Current Stock Price for Matinas BioPharma Hldgs (MTNB)?

The stock price for Matinas BioPharma Hldgs (AMEX: MTNB) is $0.1938 last updated April 18, 2024 at 5:05 PM EDT.

Does Matinas BioPharma Hldgs (MTNB) pay a dividend?

There are no upcoming dividends for Matinas BioPharma Hldgs.

When is Matinas BioPharma Hldgs (AMEX:MTNB) reporting earnings?

Matinas BioPharma Hldgs’s Q1 earnings are confirmed for Wednesday, May 8, 2024.

Is Matinas BioPharma Hldgs (MTNB) going to split?

There is no upcoming split for Matinas BioPharma Hldgs.

What sector and industry does Matinas BioPharma Hldgs (MTNB) operate in?

Matinas BioPharma Hldgs is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

-

-

-

-

-

-

-

-

-

-

-

-

-

-